Healthcare -
Biotechnology - NASDAQ - US
$ 8.25
15.2 %
$ 30.4 M
Market Cap
-0.44
P/E
TPST - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TPST - Tempest Therapeutics, Inc.
24.5 M
LAST VALUE
46.58%
2 YEAR CAGR
-1.88%
5 YEAR CAGR
-7.20%
10 YEAR CAGR